ArticleScientific reports2025

Sugemalimab plus chemotherapy versus chemotherapy for advanced gastric cancer in China: a cost-effectiveness analysis.

Xiaojie Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.